Mallinckrodt Investors Get Initial OK For $5.5M Settlement
By Sydney Price · May 28, 2025, 6:31 PM EDT
Investors of drugmaker Mallinckrodt received preliminary approval of their $5.5 million settlement with two executives and a director of the company Wednesday, ending the investors' claims they were misled into believing...
To view the full article, register now.